Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia
Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 Mar 2017
|
| In: |
Molecular & cellular oncology
Year: 2017, Jahrgang: 4, Heft: 2, Pages: 1-3 |
| ISSN: | 2372-3556 |
| DOI: | 10.1080/23723556.2017.1291396 |
| Online-Zugang: | Verlag, Volltext: https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396 Resolving-System, Volltext: https://dx.doi.org/10.1080/23723556.2017.1291396 |
| Verfasserangaben: | Stefanie Göllner and Carsten Müller-Tidow |
| Zusammenfassung: | Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome |
|---|---|
| Beschreibung: | Online Resource |
| ISSN: | 2372-3556 |
| DOI: | 10.1080/23723556.2017.1291396 |